DK1353666T3 - Myeloperoxidase, en risikoindikator for cardiovasculær sygdom - Google Patents
Myeloperoxidase, en risikoindikator for cardiovasculær sygdomInfo
- Publication number
- DK1353666T3 DK1353666T3 DK02718773.1T DK02718773T DK1353666T3 DK 1353666 T3 DK1353666 T3 DK 1353666T3 DK 02718773 T DK02718773 T DK 02718773T DK 1353666 T3 DK1353666 T3 DK 1353666T3
- Authority
- DK
- Denmark
- Prior art keywords
- myeloperoxidase
- cardiovascular disease
- risk indicator
- indicator
- risk
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/26—Processes using, or culture media containing, hydrocarbons
- C12N1/28—Processes using, or culture media containing, hydrocarbons aliphatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25934001P | 2001-01-02 | 2001-01-02 | |
US28343201P | 2001-04-12 | 2001-04-12 | |
PCT/US2002/000050 WO2002062207A2 (en) | 2001-01-02 | 2002-01-02 | Myeloperoxidase, a risk indicator for cardiovascular disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1353666T3 true DK1353666T3 (da) | 2013-10-14 |
Family
ID=26947248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02718773.1T DK1353666T3 (da) | 2001-01-02 | 2002-01-02 | Myeloperoxidase, en risikoindikator for cardiovasculær sygdom |
Country Status (8)
Country | Link |
---|---|
US (10) | US7223552B2 (da) |
EP (1) | EP1353666B1 (da) |
AU (1) | AU2002249893B2 (da) |
BR (1) | BR0206273A (da) |
CA (1) | CA2440978C (da) |
DK (1) | DK1353666T3 (da) |
ES (1) | ES2429528T3 (da) |
WO (1) | WO2002062207A2 (da) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1353666T3 (da) | 2001-01-02 | 2013-10-14 | Cleveland Clinic Foundation | Myeloperoxidase, en risikoindikator for cardiovasculær sygdom |
US7780950B2 (en) | 2002-01-02 | 2010-08-24 | The Cleveland Clinic Foundation | Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents |
JP2005532792A (ja) | 2002-04-17 | 2005-11-04 | ザ クリーブランド クリニック ファウンデーション | 治療薬剤の抗炎症作用および抗酸化作用をモニターするための全身マーカー |
US20050048660A1 (en) * | 2003-09-02 | 2005-03-03 | Case Western Reserve University | Biomarker of maternal alcohol use during pregnancy |
US7459286B1 (en) * | 2003-10-22 | 2008-12-02 | The Cleveland Clinic Foundation | Assessing the risk of a major adverse cardiac event in patients with chest pain |
US7781219B2 (en) | 2003-12-05 | 2010-08-24 | The Cleveland Clinic Foundation | Risk markers for cardiovascular disease |
US20050244892A1 (en) * | 2004-02-27 | 2005-11-03 | Lazar Mitchell A | Resistin as a marker and therapeutic target for cardiovascular disease |
US7306562B1 (en) | 2004-04-23 | 2007-12-11 | Medical Software, Llc | Medical risk assessment method and program product |
US8852879B2 (en) * | 2004-04-29 | 2014-10-07 | The Children's Hospital Of Philadelphia | Materials and methods for the detection of nitrated fibrinogen |
US20050244905A1 (en) * | 2004-04-29 | 2005-11-03 | Harry Ischiropoulos | Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation |
CA2581929C (en) * | 2004-07-19 | 2016-10-18 | University Of Washington | Methods for assessing the risk for development of cardiovascular disease |
WO2006020498A2 (en) * | 2004-08-11 | 2006-02-23 | The Cleveland Clinic Foundation | Therapeutic agents and methods for cardiovascular disease |
US7195891B2 (en) * | 2004-08-11 | 2007-03-27 | General Atomics | Methods and compositions of enzymatic cycling based assays for myeloperoxidase |
US20060183174A1 (en) * | 2005-02-11 | 2006-08-17 | Leong Ng | Diagnosis |
US7972802B2 (en) * | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
US20080171344A1 (en) * | 2006-12-22 | 2008-07-17 | Kapsner Kenneth P | Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase |
US20080286818A1 (en) * | 2007-05-18 | 2008-11-20 | Datwyler Saul A | Blood sample handling methods for improved assays for myeloperoxidase |
US20090148866A1 (en) * | 2007-05-18 | 2009-06-11 | Abbott Laboratories | Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase |
CA2686465A1 (en) * | 2007-05-18 | 2009-02-19 | Abbott Laboratories | Antibodies and improved test sample handling methods for use in assays for myeloperoxidase |
US20090134325A1 (en) * | 2007-11-27 | 2009-05-28 | Goldman Mildred M | Methods for detecting estradiol by mass spectrometry |
US8916385B2 (en) | 2007-12-13 | 2014-12-23 | Quest Diagnostics Investments, Inc. | Methods for detecting estrone by mass spectrometry |
US20090162876A1 (en) * | 2007-12-20 | 2009-06-25 | Abbott Laboratories | Myeloperoxidase assays |
US20090208992A1 (en) * | 2008-02-20 | 2009-08-20 | The Cleveland Clinic Foundation | Paraoxonase 1 enzymatic activity, a risk indicator for major adverse cardiovascular events |
EP2268305A4 (en) * | 2008-03-14 | 2011-08-03 | Cleveland Clinic Foundation | PROPORTION OF PARTICLE NUMBER OF OXIDIZED PARAOXONASE 1 TO PARAOXONASE 1 / HDL AS A RISK MARKER FOR CARDIOVASCULAR DISEASES |
US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
EP2443456A4 (en) * | 2009-06-15 | 2013-02-20 | Cleveland Clinic Foundation | METABOLITES OF ARGININE METHYLATES AS PREDICTORS OF CARDIOVASCULAR DISEASE RISK |
US20110034419A1 (en) * | 2009-06-27 | 2011-02-10 | Musc Foundation For Research Development | Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease |
AU2011215826B2 (en) * | 2010-02-10 | 2016-09-29 | Cleveland Heartlab Llc | Compositions and methods for predicting cardiovascular events |
EP2366431A1 (en) | 2010-03-19 | 2011-09-21 | Universitätsklinikum Hamburg-Eppendorf | Myeloperoxidase as a target in atrial fibrillation |
WO2011133581A1 (en) | 2010-04-19 | 2011-10-27 | General Atomics | Methods and compositions for assaying enzymatic activity of myeloperoxidase in blood samples |
JP5337096B2 (ja) | 2010-04-28 | 2013-11-06 | 株式会社日立製作所 | 動脈硬化の評価法 |
EP2385374B2 (en) | 2010-05-05 | 2018-02-28 | Zora Biosciences OY | Lipidomic biomarkers for atherosclerosis and cardiovascular disease |
US9201080B2 (en) | 2010-06-20 | 2015-12-01 | Zora Biosciences Oy | Lipidomic biomarkers for identification of high-risk coronary artery disease patients |
GB201021509D0 (en) * | 2010-12-20 | 2011-02-02 | Reactivlab Ltd | Assay method |
KR101660328B1 (ko) | 2014-01-14 | 2016-09-27 | 한국과학기술연구원 | 심혈관 질환 진단용 바이오 마커 |
EP3435847A1 (en) | 2016-04-01 | 2019-02-06 | Cardiac Pacemakers, Inc. | Alert management for physiological event detection |
AU2017319508A1 (en) * | 2016-09-01 | 2019-04-18 | St. Laurent Institute | Blood RNA biomarkers of coronary artery disease |
KR102003309B1 (ko) | 2016-12-05 | 2019-07-25 | 한국과학기술연구원 | 대사체 및 임상지표를 활용한 관상동맥 심장질환 진단용 키트 및 기초 정보 제공 방법 |
US20180168779A1 (en) * | 2016-12-19 | 2018-06-21 | Sten R. Gerfast | Anchoring system for prosthetics |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2765299A (en) * | 1952-06-27 | 1956-10-02 | Armour & Co | Recovery of serum albumin |
US5846799A (en) | 1988-06-14 | 1998-12-08 | La Region Wallone | Human myeloperoxidase and its therapeutic application |
US5460961A (en) * | 1988-06-14 | 1995-10-24 | La Region Wallonne | Human myeloperoxidase and its therapeutic application |
FR2644894B1 (fr) * | 1989-03-24 | 1994-05-13 | Sanofi | Trousse et methode de dosage enzymatique applicables a des cellules entieres |
IT8921788A0 (it) | 1989-09-21 | 1989-09-21 | Diesse Diagnostica | Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici. |
US5200319A (en) * | 1989-10-27 | 1993-04-06 | The General Hospital Corporation | Diagnosis of glomerulonephritis |
US5604105B1 (en) | 1990-10-12 | 1999-08-24 | Spectral Diagnostics Inc | Method and device for diagnosingand distinguishing chest pain in early onset thereof |
US5776892A (en) * | 1990-12-21 | 1998-07-07 | Curative Health Services, Inc. | Anti-inflammatory peptides |
US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
US6962795B1 (en) * | 1992-05-11 | 2005-11-08 | Dendreon Corporation | Neutrophil inhibitors |
US6191169B1 (en) * | 1992-08-28 | 2001-02-20 | City Of Hope | Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
WO1996004311A1 (en) * | 1994-08-03 | 1996-02-15 | University Of Alabama At Birmingham Research Foundation | Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease |
US5871946A (en) * | 1995-05-18 | 1999-02-16 | Coulter Corporation | Method for determining activity of enzymes in metabolically active whole cells |
TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
US5731208A (en) | 1996-09-09 | 1998-03-24 | Washington University | Method of detecting conditions indicative of atherosclerosis |
US6268220B1 (en) | 1996-09-09 | 2001-07-31 | Washington University | Diagnostic method for atherosclerosis |
US5874313A (en) * | 1997-03-25 | 1999-02-23 | Oy Aboatech Ab | Method for quantifying oxidation parameters of low density lipoproteins and use thereof |
ES2239801T3 (es) | 1997-04-02 | 2005-10-01 | The Brigham And Women's Hospital, Inc. | Uso de un agente para disminuir el riesgo de enfermedad cardiovascular. |
US7030152B1 (en) * | 1997-04-02 | 2006-04-18 | The Brigham And Women's Hospital, Inc. | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
US6037323A (en) * | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6133039A (en) | 1998-02-09 | 2000-10-17 | Washinton University | In vivo method for determination of oxidative stress |
US6096556A (en) | 1998-02-09 | 2000-08-01 | Washington University | Method for the determination of oxidative stress |
US6953666B1 (en) | 1998-11-06 | 2005-10-11 | Emory University | Biomarkers for oxidative stress |
AU756780B2 (en) * | 1999-03-29 | 2003-01-23 | Asahi Kasei Kabushiki Kaisha | Method for determining a while blood cell count of a whole blood sample |
AU2002213843B2 (en) * | 2000-11-10 | 2008-02-07 | F. Hoffmann-La Roche Ltd. | Apolipoprotein analogues |
ES2375268T3 (es) | 2000-12-14 | 2012-02-28 | The Brigham And Women's Hospital, Inc. | Marcadores inflamatorios para la detección y prevención de diabetes mellitus. |
BE1013881A6 (fr) * | 2000-12-21 | 2002-11-05 | Univ Bruxelles | Fractions de ldl oxydees, procede d'obtention et utilisation a but diagnostique ou therapeutique. |
DK1353666T3 (da) | 2001-01-02 | 2013-10-14 | Cleveland Clinic Foundation | Myeloperoxidase, en risikoindikator for cardiovasculær sygdom |
US20030008373A1 (en) * | 2001-04-17 | 2003-01-09 | Myriad Genetics, Incorporated | APOA1-interacting proteins and use thereof |
CA2344007A1 (en) * | 2001-04-12 | 2002-10-12 | Michael R. Buchanan | Cardiovascular disease and thrombotic risk diagnostic tests |
US20030119792A1 (en) | 2001-09-28 | 2003-06-26 | Roca Manuel Merlos | Method of inhibiting the production and/or effects of intestinal pro-inflammatory cytokines, prostaglandins and others |
US20120129708A1 (en) * | 2010-05-19 | 2012-05-24 | Cleveland Heart Lab | Compositions and methods for predicting cardiovascular events |
-
2002
- 2002-01-02 DK DK02718773.1T patent/DK1353666T3/da active
- 2002-01-02 EP EP02718773.1A patent/EP1353666B1/en not_active Expired - Lifetime
- 2002-01-02 CA CA2440978A patent/CA2440978C/en not_active Expired - Lifetime
- 2002-01-02 WO PCT/US2002/000050 patent/WO2002062207A2/en active IP Right Grant
- 2002-01-02 US US10/039,753 patent/US7223552B2/en not_active Expired - Lifetime
- 2002-01-02 BR BRPI0206273-9A patent/BR0206273A/pt not_active IP Right Cessation
- 2002-01-02 ES ES02718773T patent/ES2429528T3/es not_active Expired - Lifetime
- 2002-01-02 AU AU2002249893A patent/AU2002249893B2/en not_active Expired
-
2005
- 2005-12-20 US US11/313,012 patent/US9164095B2/en not_active Expired - Fee Related
-
2007
- 2007-05-25 US US11/753,799 patent/US9170260B2/en not_active Expired - Fee Related
-
2010
- 2010-10-25 US US12/911,425 patent/US9140703B2/en not_active Expired - Fee Related
-
2011
- 2011-07-14 US US13/183,165 patent/US20110287449A1/en not_active Abandoned
-
2015
- 2015-01-07 US US14/591,381 patent/US9612242B2/en not_active Expired - Lifetime
- 2015-12-30 US US14/984,072 patent/US9435808B2/en not_active Expired - Lifetime
-
2016
- 2016-04-22 US US15/135,743 patent/US20160238604A1/en not_active Abandoned
- 2016-04-22 US US15/135,757 patent/US9581597B2/en not_active Expired - Fee Related
- 2016-04-22 US US15/135,730 patent/US9575065B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1353666A2 (en) | 2003-10-22 |
US20160238604A1 (en) | 2016-08-18 |
US9140703B2 (en) | 2015-09-22 |
US9164095B2 (en) | 2015-10-20 |
US20110287449A1 (en) | 2011-11-24 |
ES2429528T3 (es) | 2013-11-15 |
WO2002062207A2 (en) | 2002-08-15 |
US20060105408A1 (en) | 2006-05-18 |
US7223552B2 (en) | 2007-05-29 |
EP1353666B1 (en) | 2013-07-03 |
US9435808B2 (en) | 2016-09-06 |
US20080009020A1 (en) | 2008-01-10 |
CA2440978C (en) | 2013-04-02 |
AU2002249893B2 (en) | 2007-05-24 |
US20150185217A1 (en) | 2015-07-02 |
CA2440978A1 (en) | 2002-08-15 |
US20020164662A1 (en) | 2002-11-07 |
US9612242B2 (en) | 2017-04-04 |
BR0206273A (pt) | 2006-11-21 |
US20160238605A1 (en) | 2016-08-18 |
US20160238603A1 (en) | 2016-08-18 |
US20160109448A1 (en) | 2016-04-21 |
US9170260B2 (en) | 2015-10-27 |
US9581597B2 (en) | 2017-02-28 |
WO2002062207A3 (en) | 2002-10-31 |
US9575065B2 (en) | 2017-02-21 |
US20110152224A1 (en) | 2011-06-23 |
EP1353666A4 (en) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1353666T3 (da) | Myeloperoxidase, en risikoindikator for cardiovasculær sygdom | |
BR0201416B1 (pt) | mÁquina de voluta. | |
BR0116926B1 (pt) | árvore de manivelas em um compressor de capacidade dupla. | |
DE60122669D1 (de) | A/D-Wandler | |
NO20042699L (no) | Fremgangsmate for overvaking av en foler. | |
PT1379220E (pt) | Capsulas de inalacao | |
NL1020948A1 (nl) | Verbeterd lampontwerp. | |
NO20041165L (no) | Avstengningsanordning. | |
FR2829460B3 (fr) | Trottinette de jogging | |
NO20041134L (no) | Likestromsomformer. | |
DE60207081D1 (de) | Hybridaufblasvorrichtung | |
BR0200651B1 (pt) | dispositivo de estribo para uma motocicleta. | |
DE60208495D1 (de) | Kontrastphantom | |
ITMI20020092A0 (it) | Un impianto | |
FR2822635B1 (fr) | Secateur a moindre effort resistant | |
DE50208629D1 (de) | Pedal | |
FR2806074B1 (fr) | Machine i.s. (a sections individuelles) | |
DE50207829D1 (de) | Pedal | |
ITTO20020005A0 (it) | Motociclo. | |
ITTO20020104A1 (it) | Compressore a stantuffo. | |
ITTO20020348A0 (it) | Motociclo. | |
IT1318610B1 (it) | Micomelanine a struttura polinaftoica. | |
ITMI20022502A1 (it) | Meccanismo a pedivelle. | |
ES1048062Y (es) | Maquina de arar. | |
DE50211331D1 (de) | Pedal |